{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:30:41Z","timestamp":1792798241173,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/iae.0b013e3181e7978e","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T11:23:19Z","timestamp":1284636199000},"page":"1579-1587","source":"Crossref","is-referenced-by-count":68,"title":["A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION"],"prefix":"10.1097","volume":"30","author":[{"given":"Robert B","family":"Nussenblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Nida","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Faia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meyerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Wroblewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti R","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States.","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration.","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","article-title":"Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?","volume":"122","author":"Cousins","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF00920033","article-title":"Autoantibodies to retinal astrocytes associated with age-related macular degeneration.","volume":"228","author":"Penfold","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.174.9.5187","article-title":"Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis.","volume":"174","author":"Li","year":"2005","journal-title":"J Immunol"},{"key":"R6-4-20210130","first-page":"964","article-title":"Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.","volume":"10","author":"Dejneka","year":"2004","journal-title":"Mol Vis"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0420.2006.00858.x","article-title":"The treatment of multifocal choroiditis associated choroidal neovascularization with sirolimus (rapamycin).","volume":"85","author":"Nussenblatt","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","article-title":"Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with AMD after bevacizumab treatment.","volume":"29","author":"Roh","year":"2009","journal-title":"Retina"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02150948","article-title":"Senile macular degeneration: the involvement of immunocompetent cells.","volume":"223","author":"Penfold","year":"1985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2567.2005.02173.x","article-title":"Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.","volume":"115","author":"Patel","year":"2005","journal-title":"Immunology"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1074\/mcp.M800453-MCP200","article-title":"Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers.","volume":"8","author":"Gu","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/eye.1990.86","article-title":"Macrophages related to Bruchs membrane in age-related macular degeneration.","volume":"4","author":"Killingsworth","year":"1990","journal-title":"Eye"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1350-9462(00)00025-2","article-title":"Immunological and aetiological aspects of macular degeneration.","volume":"20","author":"Penfold","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye.","volume":"134","author":"Anderson","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.1073\/pnas.0703933104","article-title":"A variant of mitochondrial protein LOC387715\/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.","volume":"104","author":"Kanda","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/bjo.2007.123190","article-title":"Interleukin-8 promoter polymorphism -251A\/T is a risk factor for age-related macular degeneration.","volume":"92","author":"Goverdhan","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R18-4-20210130","first-page":"2153","article-title":"PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.","volume":"13","author":"Leveziel","year":"2007","journal-title":"Mol Vis"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajo.2007.06.025","article-title":"Age-related macular degeneration and the immune response: implications for therapy.","volume":"144","author":"Nussenblatt","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R20-4-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2008.10.001","article-title":"Molecular pathology of age-related macular degeneration.","volume":"28","author":"Ding","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm1709","article-title":"Oxidative damage-induced inflammation initiates age-related macular degeneration.","volume":"14","author":"Hollyfield","year":"2008","journal-title":"Nat Med"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","article-title":"Regression of neovascular age-related macular degeneration following infliximab therapy.","volume":"139","author":"Markomichelakis","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-8411(03)00113-6","article-title":"Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.","volume":"21","author":"Nussenblatt","year":"2003","journal-title":"J Autoimmun"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1517\/14712598.7.10.1583","article-title":"Daclizumab.","volume":"7","author":"Mottershead","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action.","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.154.2.922","article-title":"Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.","volume":"154","author":"Martin","year":"1995","journal-title":"J Immunol"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"R29-4-20210130","first-page":"434","article-title":"Age-related macular degeneration: an immunologically driven disease.","volume":"10","author":"Nussenblatt","year":"2009","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3181e7978e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T10:33:44Z","timestamp":1685788424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201011000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181e7978e","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}